Cargando…

An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems

Detalles Bibliográficos
Autores principales:	Younus, Manal Mohammed, Al-Jumaili, Ali Azeez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	University of Minnesota Libraries Publishing 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401377/ https://www.ncbi.nlm.nih.gov/pubmed/36033117 http://dx.doi.org/10.24926/iip.v12i4.4294

Ejemplares similares

The whole experience of public hospital physicians from several specialties with biopharmaceutical effectiveness, safety, adverse drug reactions and interchangeability: A qualitative study
por: Fahmi, Hiba Leith, et al.
Publicado: (2022)

The Epidemic of Substandard and Falsified Medications in Iraq: Evaluating the Effectiveness of National Pharmacovigilance Alerts to Community Pharmacies
por: Al-Jumaili, Ali Azeez, et al.
Publicado: (2021)

Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines
por: Albalawi, Omar M., et al.
Publicado: (2022)

Post-marketing safety surveillance of the rotavirus vaccine in India
por: Kang, Gagandeep, et al.
Publicado: (2023)

The Pharmacist’s Missing Role in the COVID-19 Pandemic
por: Ahjel, Salam W., et al.
Publicado: (2020)

Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China
por: Meng, Fan-Ya, et al.
Publicado: (2017)

Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
por: Tavares-Da-Silva, Fernanda, et al.
Publicado: (2020)

Comparison of the post-marketing safety profile between influenza and COVID-19 vaccines: An analysis of the vaccine adverse event reporting system
por: Al-Ahmari, Abdullah K., et al.
Publicado: (2022)

Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017–2021)
por: Eun, Byung-Wook, et al.
Publicado: (2023)

Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
por: Li, Chunxiao, et al.
Publicado: (2018)

A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project
por: Lentz, Steven R, et al.
Publicado: (2014)

Can developing countries face novel coronavirus outbreak alone? The Iraqi situation
por: Mikhael, Ehab Mudher, et al.
Publicado: (2020)

Organization factors influencing nurse ability to prevent and detect adverse drug events in public hospitals using a patient safety model
por: Al-Jumaili, Ali Azeez, et al.
Publicado: (2021)

Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023)

COVID-19 vaccine post-marketing surveillance: Cardiovascular doctors have a role to play!
por: Fournier, Dorine, et al.
Publicado: (2021)

Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance
por: Fiore, Joseph, et al.
Publicado: (2021)

Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency
por: Kälkner, Karl Mikael, et al.
Publicado: (2023)

Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis
por: Rubin, David T., et al.
Publicado: (2021)

2776. Post-marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Review of Spontaneous Reports Since Introduction
por: Tavares-Da-Silva, Fernanda, et al.
Publicado: (2019)

Safety and Efficacy of Zonisamide in Patients with Epilepsy: A Post-Marketing Surveillance Study
por: Lee, Hye Jin, et al.
Publicado: (2015)

Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan†
por: Kurita, Tomoko, et al.
Publicado: (2014)

Efficacy, Safety, and Durability of Brolucizumab: An 8-Month Post-Marketing Surveillance Analysis
por: Saba, Nicholas J, et al.
Publicado: (2023)

Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system
por: Xiong, Rui, et al.
Publicado: (2023)

Pharmacist role to enhance the prescribing of hospital discharge medications for patients after heart attack
por: Jabri, Amina M., et al.
Publicado: (2020)

Evaluating Factors Related to the Abuse of Oral Corticosteroids among Community Pharmacy Customers: Using Theory of Reasoned Action
por: Alfetlawi, Bashar G., et al.
Publicado: (2020)

Knowledge, Perception and Attitude Regarding Generic Medicines among Iraqi Physicians
por: Mahdi, Layla Abdullah, et al.
Publicado: (2020)

Influence of Pharmacy Characteristics and Customer Quality of Life on Satisfaction of Community Pharmacy Customers
por: Al-Jumaili, Ali Azeez, et al.
Publicado: (2020)

Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system
por: Betancourt-Cravioto, Miguel, et al.
Publicado: (2021)

Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: A post-marketing surveillance study
por: Bravo, Lulu, et al.
Publicado: (2014)

Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)
por: Shin, Son Moon, et al.
Publicado: (2016)

Safety and Effectiveness of Molnupiravir (LAGEVRIO(®)) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
por: Kimata, Masahiro, et al.
Publicado: (2023)

Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan
por: Saida, Takahiko, et al.
Publicado: (2017)

Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
por: Kim, Hyeongyeong, et al.
Publicado: (2021)

Safety and Effectiveness of Varenicline in Korean Smokers: A Nationwide Post-Marketing Surveillance Study
por: Ock, Minsu, et al.
Publicado: (2022)

Safety and effectiveness of ustekinumab in Crohn's disease: Interim results of post‐marketing surveillance in Japan
por: Yokoyama, Seiji, et al.
Publicado: (2021)

Safety of Tacrolimus in Autoimmune Disease: Results From Post-marketing Surveillance in South Korea
por: Yoo, Wan-Hee, et al.
Publicado: (2021)

Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea
por: Choe, Sunho, et al.
Publicado: (2023)

Planning for COVID-19 vaccines safety surveillance
por: Kochhar, Sonali, et al.
Publicado: (2020)

Optimizing safety surveillance for COVID-19 vaccines
por: Chandler, Rebecca E.
Publicado: (2020)

Immunotherapeutics for Covid-19 and post vaccination surveillance
por: Sampath Kumar, N. S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mqb81f1sqr6ipt0j33kebvt3s4